SHC · NASDAQ · Medical - Diagnostics & Research

Sotera Health

Provides contract sterilization, gamma technologies, and testing services for healthcare-product safety.

$19.27
After-hours close0.00 (0.00%)
At close$19.27(−1.08%)

Breakdown13F · Form 4

Institutions 106.22%Insiders 2.29%

A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.

Shares outstanding 285.17M · Float 154.14M · 54.1% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
WP XI Partners, L.P.73.04M25.70%13GNov 12, 2025
Sessa Capital Im, L.P.27.05M9.49%13FAug 14, 2026
Darsana Capital Partners LP27.00M9.47%13FAug 14, 2026
BlackRock, Inc.24.15M8.47%13FAug 7, 2026
Sculptor Capital LP24.00M8.42%13FAug 14, 2026

Institutions13F, as of Jun 30, 2026

317 holders · 302.90M shares · 59 new positions · 224 increased · 65 reduced · 40 closed

HolderShares% outstandingChg q/qFiled
Sessa Capital Im, L.P.27.05M9.49%+4.00MAug 14, 2026
Darsana Capital Partners LP27.00M9.47%+1.00MAug 14, 2026
BlackRock, Inc.24.15M8.47%+3.30MAug 7, 2026
Sculptor Capital LP24.00M8.42%+2.28MAug 14, 2026
Sachem Head Capital Management LP15.56M5.46%+3.92MAug 14, 2026
Vanguard Capital Management LLC12.17M4.27%+1.44MAug 13, 2026
Vanguard Portfolio Management LLC11.95M4.19%+1.34MAug 13, 2026
AQR Capital Management LLC10.73M3.76%+4.01MAug 14, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
WP XI Partners, L.P.25.70%73.04M13GNov 12, 2025
Darsana Capital Partners LP8.80%25.00M13GNov 14, 2025
Sculptor Capital LP7.39%21.00M13GFeb 13, 2026
BlackRock, Inc.6.20%17.74M13GJan 21, 2026
Sessa Capital (Master), L.P.5.60%15.92M13GFeb 17, 2026
Sachem Head Capital Management LP5.46%15.56M13GMay 15, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
Michael B. Jr. Petrasdirector, officer: Executive Chairman4.37M1.53%Aug 19, 2026
Alton Shaderdirector, officer: Chief Executive Officer375.9K0.13%May 27, 2026
Michael P. Rutzofficer: President of Sterigenics334.3K0.12%Aug 11, 2026
Alexander Dimitriefofficer: Former SVP, GC and Sec.312.0K0.11%Apr 2, 2026
Jonathan M. Lyonsofficer: Sr. Vice President, CFO217.3K0.08%Aug 7, 2026
Ann R. Kleedirector140.9K0.05%May 27, 2026
Sean Laurence Cunninghamdirector95.8K0.03%May 27, 2026
Ruoxi Chendirector95.8K0.03%May 27, 2026
James Nearydirector95.8K0.03%May 27, 2026
Vincent K. Petrelladirector95.8K0.03%May 27, 2026

5 people have not refiled in the last 18 months (872.6K shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 17, 2026
Michael B. Jr. Petrasdirector, officer: Executive Chairman
Sale · 2 lots1,144,515$18.504,367,305
Aug 7, 2026
Michael P. Rutzofficer: President of Sterigenics
Sale150,000$18.84334,279
May 13, 2026
GTCR Investment Xi LLCdirector, 10 percent owner:
Sale12,735,301$15.170
May 13, 2026
Warburg Pincus & Co.director, 10 percent owner:
Sale19,102,952$15.170
Mar 6, 2026
GTCR Investment Xi LLCdirector, 10 percent owner:
Sale10,000,000$15.2712,735,301
Mar 6, 2026
Warburg Pincus & Co.director, 10 percent owner:
Sale15,000,000$15.2719,102,952
Dec 8, 2025
Michael B. Jr. Petrasdirector, officer: Chairman & CEO
Sale · 3 lots750,000$16.45552,790
Dec 3, 2025
GTCR Investment Xi LLCdirector, 10 percent owner:
Sale6,480,000$16.3322,735,301
Dec 3, 2025
Warburg Pincus & Co.director, 10 percent owner:
Sale9,720,000$16.3334,102,952
Nov 10, 2025
Warburg Pincus & Co.director, 10 percent owner:
Sale18,000,000$15.6543,822,952

CongressHouse and Senate disclosures

Not reported.